LambdaVision is a company that develops a protein-based, retinal implant technology. It utilizes a light-activated protein, bacteriorhodopsin, to stimulate the retinas of patients with impaired vision or sight loss due to retinal degenerative diseases, including age-related macular degeneration and retinitis pigmentosa.